Hernandez L - Search Results

1

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.

Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM. Annunziata CM, et al. Among authors: hernandez l. Blood. 2011 Feb 24;117(8):2396-404. doi: 10.1182/blood-2010-04-278788. Epub 2010 Dec 16. Blood. 2011. PMID: 21163924 Free PMC article.

2

Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.

Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM. Hernandez L, et al. Cancer Res. 2010 May 15;70(10):4005-14. doi: 10.1158/0008-5472.CAN-09-3912. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424119 Free PMC article.

3

Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.

Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC. Annunziata CM, et al. Among authors: hernandez lf. Cancer. 2010 Jul 1;116(13):3276-84. doi: 10.1002/cncr.25190. Cancer. 2010. PMID: 20564628 Free PMC article.

4

IKK-ε coordinates invasion and metastasis of ovarian cancer.

Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM. Hsu S, et al. Among authors: hernandez l. Cancer Res. 2012 Nov 1;72(21):5494-504. doi: 10.1158/0008-5472.CAN-11-3993. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942254 Free PMC article.

5

Recent technological advances in using mouse models to study ovarian cancer.

House CD, Hernandez L, Annunziata CM. House CD, et al. Among authors: hernandez l. Front Oncol. 2014 Feb 13;4:26. doi: 10.3389/fonc.2014.00026. eCollection 2014. Front Oncol. 2014. PMID: 24592355 Free PMC article. Review.

6

Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.

Szabova L, Bupp S, Kamal M, Householder DB, Hernandez L, Schlomer JJ, Baran ML, Yi M, Stephens RM, Annunziata CM, Martin PL, Van Dyke TA, Weaver Ohler Z, Difilippantonio S. Szabova L, et al. Among authors: hernandez l. PLoS One. 2014 Apr 18;9(4):e95649. doi: 10.1371/journal.pone.0095649. eCollection 2014. PLoS One. 2014. PMID: 24748377 Free PMC article.

7

The small molecule NSC676914A is cytotoxic and differentially affects NFκB signaling in ovarian cancer cells and HEK293 cells.

Sagher E, Hernandez L, Heywood C, Pauly GT, Young MR, Schneider J, Colburn NH, Annunziata CM. Sagher E, et al. Among authors: hernandez l. Cancer Cell Int. 2014 Aug 12;14:75. doi: 10.1186/s12935-014-0075-y. eCollection 2014. Cancer Cell Int. 2014. PMID: 25324692 Free PMC article.

8

In vitro enrichment of ovarian cancer tumor-initiating cells.

House CD, Hernandez L, Annunziata CM. House CD, et al. Among authors: hernandez l. J Vis Exp. 2015 Feb 18;(96):52446. doi: 10.3791/52446. J Vis Exp. 2015. PMID: 25742116 Free PMC article.

9

Caspase 8 expression may determine the survival of women with ovarian cancer.

Kim M, Hernandez L, Annunziata CM. Kim M, et al. Among authors: hernandez l. Cell Death Dis. 2016 Jan 14;7(1):e2045. doi: 10.1038/cddis.2015.398. Cell Death Dis. 2016. PMID: 26775699 Free PMC article. No abstract available.

10

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.

Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, Noonan AM, Annunziata CM. Hernandez L, et al. Gynecol Oncol. 2016 Aug;142(2):332-40. doi: 10.1016/j.ygyno.2016.05.028. Epub 2016 May 28. Gynecol Oncol. 2016. PMID: 27235858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,287 results

Search Page

Filters